Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietary Impacts on Sitagliptin in Type 2 Diabetes
NCT02312063Phase 4Completed
- Sponsor
- Kansai Electric Power Company Hospital
- Start
- Feb 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Kansai Electric Power Company Hospital. Started Feb 2015; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02312063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312063.